Second to fourth digit ratio: a predictor of prostate-specific antigen level and the presence of prostate cancer

被引:35
|
作者
Jung, Han [1 ]
Kim, Khae Hawn [1 ]
Yoon, Sang Jin [1 ]
Kim, Tae Beom [1 ]
机构
[1] Gachon Univ Gil Hosp, Dept Urol, Inchon 405760, South Korea
关键词
Digit ratio; prostate volume; prostate-specific antigen; prostate cancer; ANDROGEN RECEPTOR GENE; RACIAL-DIFFERENCES; CAG REPEAT; AFRICAN-AMERICAN; FINGER-LENGTH; SEXUAL SELECTION; MEN; TESTOSTERONE; HYPERPLASIA; HORMONE;
D O I
10.1111/j.1464-410X.2010.09490.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? The Homeobox genes, Hox a and d, control urinogenital system differentiation and digit development. The patterns of digit formation may be related to gonad function and may be reflected in 2nd to 4th digit ratio (digit ratio). Digit ratio is negatively correlated with prenatal testosterone levels and androgen receptor activity which is related to the increased prostate cancer risk. Patients with a lower digit ratio have a higher risk of prostate biopsy due to high PSA level, and of prostate cancer. Digit ratio could be a predictor of high PSA level and the presence of prostate cancer. OBJECTIVE To investigate the relationships between the 2nd to 4th digit ratio (digit ratio) and prostate volume, prostate-specific antigen (PSA) level, and the presence of prostate cancer. PATIENTS AND METHODS Of the men that presented with lower urinary tract symptoms (LUTS) at a single tertiary academic center, 366 men aged 40 or older with a PSA level < 40 ng/mL were prospectively enrolled. Right-hand 2nd and 4th digit lengths were measured prior to the PSA determinations and transrectal ultrasonography (TRUS). Prostate volumes were measured by TRUS without information about digit length. Patients with a PSA level >= 3 ng/mL underwent prostate biopsy. RESULTS No relationship was found between prostate volume and digit ratio [correlation coefficient (r) = -0.038, P = 0.466]. But, significant negative correlations were found between digit ratio and PSA (r = -0.140, P = 0.007). When the patients were divided into two groups (Group A: digit ratio < 0.95, n = 184; Group B: digit ratio >= 0.95, n = 182), Group A had a higher mean PSA level than Group B (3.26 +/- 5.54 ng/mL vs 1.89 +/- 2.24 ng/mL, P = 0.002) and had significantly higher risks of prostate biopsy [odds ratio (OR) = 1.75, 95% CI = 1.07-2.84] and prostate cancer (OR = 3.22, 95% CI = 1.33-7.78). CONCLUSIONS Patients with a lower digit ratio have higher risks of prostate biopsy and prostate cancer.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 50 条
  • [21] Do Changes in a High Serum Prostate-Specific Antigen Level and the Free/Total Prostate-Specific Antigen Ratio after Antibiotic Treatment Rule Out Biopsy and the Suspicion of Cancer?
    Dirim, Ayhan
    Tekin, Mehmet Ilteris
    Koyluoglu, Eser
    Oguzulgen, Ahmet Ibrahim
    Peskircioglu, Levent
    Ozkardes, Hakan
    UROLOGIA INTERNATIONALIS, 2009, 82 (03) : 266 - 269
  • [22] Derivatives of prostate-specific antigen as predictors of incidental prostate cancer
    Froehner, Michael
    Buck, Lena Marie
    Koch, Rainer
    Hakenberg, Oliver W.
    Wirth, Manfred P.
    BJU INTERNATIONAL, 2009, 104 (01) : 25 - 28
  • [23] Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer
    Moon, DG
    Cheon, J
    Kim, JJ
    Yoon, DK
    Koh, SK
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (09) : 455 - 462
  • [24] A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
    Auprich, Marco
    Augustin, Herbert
    Budaeus, Lars
    Kluth, Luis
    Mannweiler, Sebastian
    Shariat, Shahrokh F.
    Fisch, Margit
    Graefen, Markus
    Pummer, Karl
    Chun, Felix K. -H.
    BJU INTERNATIONAL, 2012, 109 (11) : 1627 - 1635
  • [25] Prostate-specific antigen testing across the spectrum of prostate cancer
    Haythorn, Mark R.
    Ablin, Richard J.
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 515 - 526
  • [26] Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
    Valiente Morejon, Wilfredo
    Junco Sena, Barbara
    Padron Vega, Yoel
    Ramos Aguila, Yisel de la Caridad
    Castillo Garcia, Idelma
    FINLAY, 2015, 5 (04): : 221 - 227
  • [27] Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer
    Abdalla, I
    Ray, P
    Ray, V
    Vaida, F
    Vijayakumar, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 537 - 541
  • [28] Additional value of the ratio of serum total testosterone to total prostate-specific antigen in the diagnosis of prostate cancer in a Chinese population
    Xu, L.
    Hu, X.
    Zhu, Y.
    Lu, J.
    Xu, Y.
    Wang, G.
    Guo, J.
    ANDROLOGIA, 2018, 50 (02)
  • [29] Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression
    Akbay, Erdem
    Bozlu, Murat
    Cayan, Selahittin
    Kara, Pelin Ozcan
    Tek, Mesut
    Aytekin, Cuma
    AGING MALE, 2017, 20 (03) : 175 - 183
  • [30] Prostate-specific Antigen Testing and Prostate Cancer Screening
    Djavan, Bob
    Eckersberger, Elisabeth
    Finkelstein, Julia
    Sadri, Helen
    Taneja, Samir S.
    Lepor, Herbert
    PRIMARY CARE, 2010, 37 (03): : 441 - +